文献速递前列腺癌男科与性医学

运动训练对接受雄激素剥夺治疗的前列腺癌男性心脏代谢健康影响的系统综述与Meta分析

The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2020-08-28

该系统综述与Meta分析评估运动训练对接受雄激素剥夺治疗(ADT)的前列腺癌(PCa)男性心脏代谢健康的影响。共纳入14项随机对照试验和4项非随机研究,其中11项RCT(n=939)进入Meta分析。运动训练改善了400米步行测试、舒张压、空腹血糖、C反应蛋白及身体成分指标,但对收缩压和血脂代谢无显著影响。

要点

  • 运动训练可改善接受ADT的前列腺癌患者的功能能力、舒张压、空腹血糖和炎症标志物。
  • 运动训练可增加瘦体重、减少脂肪质量,但对收缩压和血脂无显著改善。
  • 需以心脏代谢结局为主要终点的未来干预试验证实这些初步发现。

核心结论

  • 在评估的有限研究中,运动训练可能有利地改善接受ADT的前列腺癌男性部分但非全部心脏代谢健康标志物。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、CINHAL、SCOPUS、WEB OF SCIENCE和SPORTSDICUS从建库至2020年4月。
  • 共纳入14项随机对照试验和4项非随机研究,其中11项RCT(n=939例患者)纳入Meta分析。
  • 采用Cohens d效应量和随机效应模型进行定量合成与Meta分析。

主要发现

  • 与常规护理相比,运动训练改善400米步行测试(MD -10.11秒,95%CI [-14.34, -5.88];p < 0.00001)。
  • 运动训练降低舒张压(-2.22 mmHg,95%CI [-3.82, -0.61];p = 0.007)和空腹血糖(-0.38 mmol/L,95%CI [-0.65, -0.11];p = 0.006)。
  • 运动训练降低C反应蛋白(-1.16 mg/L,95%CI [-2.11, -0.20];p = 0.02)。
  • 运动训练增加全身瘦体重(0.70 kg,95%CI [0.39, 1.01];p < 0.0001)和四肢瘦体重(0.59 kg,95%CI [0.43, 0.76];p < 0.00001)。
  • 运动训练减少全身脂肪质量(-0.67 kg,95%CI [-1.08, -0.27];p = 0.001)、全身脂肪百分比(-0.79%,95%CI [-1.16, -0.42];p < 0.0001)和躯干脂肪质量(-0.49 kg,95%CI [-0.87, -0.12];p = 0.01)。

关键数值与推荐

  • 对收缩压和血脂代谢未检测到显著效应。

临床怎么用

  • 对于接受ADT的前列腺癌男性,可考虑将运动训练作为改善功能能力、舒张压、空腹血糖、炎症状态及身体成分的辅助策略。
  • 运动训练对收缩压和血脂代谢的改善作用不显著,不应仅依赖运动来管理这些指标。

局限性

  • 结论基于评估研究的一个小子集。
  • 需要以心脏代谢结局为主要终点的未来运动干预试验来确认这些初步发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Growing evidence suggests that men exposed to androgen deprivation therapy (ADT) have an increased risk of cardiovascular disease. While exercise has shown to attenuate some adverse effects of ADT, the effects on cardiometabolic health have not been systematically evaluated. OBJECTIVE: To evaluate the effect of exercise on cardiometabolic health in men with prostate cancer (PCa) receiving ADT. METHODS: A systematic literature search of MEDLINE, EMBASE, CINHAL, SCOPUS, WEB OF SCIENCE and SPORTSDICUS from database inception to April 2020 was performed. A quantitative synthesis using Cohens d effect size and a meta-analysis using random-effects models were conducted. RESULTS: Overall, fourteen randomised controlled trials (RCTs) and four non-randomised studies were included. Eleven RCTs (n = 939 patients) were included in the meta-analysis. Exercise training improved the 400-m-walk test (MD -10.11 s, 95% CI [-14.34, -5.88]; p < 0·00001), diastolic blood pressure (-2.22 mmHg, [-3.82, -0.61]; p = 0.007), fasting blood glucose (-0.38 mmol/L, [-0.65, -0.11]; p = 0.006), C-reactive protein (-1.16 mg/L, [-2.11, -0.20]; p = 0.02), whole-body lean mass (0.70 kg, [0.39, 1.01]; p < 0.0001), appendicular lean mass (0.59 kg, [0.43, 0.76]; p < 0.00001), whole-body fat mass (-0.67 kg, [-1.08, -0.27]; p = 0.001), whole-body fat percentage (-0.79%, [-1.16, -0.42]; p < 0.0001), and trunk fat mass (-0.49 kg, [-0.87, -0.12]; p = 0.01), compared to usual care. No significant effects on systolic blood pressure or blood lipid metabolism were detected. CONCLUSIONS: In a small subset of evaluated studies, exercise may favourably improve some but not all markers of cardiometabolic health. Future exercise intervention trials with cardiometabolic outcomes as primary endpoints are needed to confirm these initial findings.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Bigaran A, Zopf E, Gardner J, et al. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2020. PMID: 32860010. doi:10.1038/s41391-020-00273-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。